Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA

Korean Journal of Radiology

Volumn 5, Issue 4, 2004, Pages 231-239

  Ryeom, Hun Kyu ^a,b   Kim, Seong Hun ^a   Kim, Jong Yeol ^a   Kim, Hye Jeong ^a   Lee, Jong Min ^a   Chang, Yong Min ^a   Kim, Yong Sun ^a   Kang, Duk Sik ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Liver, contrast media; Liver, MR; Magnetic resonance (MR), contrast media

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; GADOXETIC ACID; INDOCYANINE GREEN; LIVER ENZYME; SODIUM CHLORIDE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD VESSEL; BODY WEIGHT; CALCULATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FOURIER TRANSFORMATION; HEPATOBILIARY SYSTEM; HISTOLOGY; HISTOPATHOLOGY; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER PARENCHYMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RABBIT; RANK SUM TEST; STATISTICAL ANALYSIS; VEIN;

EID: 12744280109     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2004.5.4.231     Document Type: Article

References (29)

1. Brensilver HL, Kaplan MM. Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 1975; 68:1556-1562
2. Gohen JA, Kaplan MM. The SGOT/SGPT ratio: an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-838
3. Almersjo O, Bengmark S, Hafstrom LO, Olsson R. Enzyme and function changes after extensive liver resection in man. Ann Surg 1969;169:111-119
4. Moody FG, Rikker LF, Aldrete JS. Estimation of the functional reserve of human liver. Ann Surg 1974;180:592-598
5. Henderson JM, Warren WD. A method of measuring quantitative hepatic function and hemodynamics in cirrhosis: the changes following distal splenorenal shunt. Jpn J Surg 1986; 16:157-168
6. Hepner GW, Vesell ES. Quantitative assessment of hepatic function by breath analysis after oral administration of [14C] aminopyrine. Ann Intern Med 1975;82:632-638
7. Vesell ES. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther 1979;26:275-286
8. Hunton DB, Bollman JL, Hoffman HN. Studies of hepatic functions with indocyanine green. Gastroenterology 1960; 39:713-723
9. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298-304
10. Hashimoto M, Watanabe G. Simultaneous measurement of effective hepatic blood flow and systemic circulation. Hepatogastroentrology 2000;47:1669-1674
11. Berk PD, Potter BJ, Stremmel W. Role of plasma membrane ligand binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology 1987;7:165-176
12. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observation on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960;39:592-600
13. Wolkoff AW. The role of an albumin receptor in hepatic organic anion uptake: the controversy continues. Hepatology 1987; 7:777-779
14. Hashimoto M, Watanabe G. Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 2000;92: 222-227
15. Murase K, Tsuda T, Mochizuki T, Ikezoe J. Hepatic excretion fraction of hepatobiliary radiopharmaceuticals measured using spectral analysis. Nucl Med Commun 1999;12:1041-1045
16. Tolia V, Kottamasu SR, Tabassum D, Simpson P. The use of hepatocyte extraction fraction to evaluate neonatal cholestasis. Clin Nucl Med 1999;24:655-659
17. Brensilver HL, Kaplan MM. Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 1975;68:1556-1562
18. Proctor E, Chatamra K. Controlled induction of cirrhosis in the rat. Br J Exp Pathol 1983;64:320-330
19. Bosma A, Brouwer A, Seifert WF, Knock DL. Synergism between ethanol and carbon tetrachlorid in the generation of liver fibrosis. J Pathol 1988;156:15-21
20. McLean EK, McLean AE, Sutton PM. Instant cirrhosis: an improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br J Exp Pathol 1969;50:502-506
21. Brandao CG, Ferreira HH, Piovesana H, et al. Development of an experimental model of liver cirrhosis in rabbits. Clin Exp Pharmacol Physiol 2000;27:987-990
22. Schuhmann-Giampieri G, Mahler M, Roll G, Maibauer R, Schmitz S. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 1997;37:587-596
23. Muhler A, Oude Elferink RPJ, Weinmann HJ. Complete elimination of the hepatobiliary MR contrast agent in hepatic dysfunction: an experimental study using transport-deficient, mutant rats. MAGMA 1994;1:134-139
24. Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC. Gadolinium-ethoxybenzly-DTPA: a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992;27:612-619
25. Muhler A, Clement O, Saeed M, et al. Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects. Invest Radiol 1993;28:26-32
26. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991-22:233-237
27. Muhler A, Heinzelmann I, Weinmann HJ. Elimination of gadolinium- ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats. Invest Radiol 1994;29:213-216
28. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792
29. Muhler A, Freise CE, Kuwatsuru R, et al. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model. Radiology 1993;186:139-146